Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39268 |
Azido-PEG4-azide
Azido-PEG4-azide |
PROTAC Linker | PROTAC |
Azido-PEG4-azide 是一种基于 PEG 的 PROTAC linker,可用于合成 PROTAC。 | |||
T15870 |
m-PEG4-azide
13-Azido-2,5,8,11-tetraoxatridecane |
Others | Others |
m-PEG4-azide, also referred to as 13-Azido-2,5,8,11-tetraoxatridecane, functions as a PEG-based PROTAC linker suitable for PROTACs synthesis[1]. | |||
T16189 | N-(Azido-PEG3)-N-Boc-PEG4-acid | Others | Others |
N-(Azido-PEG3)-N-Boc-PEG4-acid is a PEG-based PROTAC linker featuring a terminal azide group, primarily employed in PROTAC synthesis[1]. | |||
T30273 |
Azido-PEG4-acrylate
|
||
Azido-PEG4-acrylate is a crosslinker containing an azide group and an acrylate group. The azide group enables Click Chemistry and the acrylate group enables Michael addition. The hydrophilic PEG spacer increases solubility in aqueous media. | |||
T16198 | N-(Azido-PEG4)-N-Boc-PEG4-NHS ester | Others | Others |
N-(Azido-PEG4)-N-Boc-PEG4-NHS ester is a PEG-based PROTAC linker featuring a terminal azide group. It is commonly employed in the synthesis of PROTACs[1]. | |||
T17503 |
Azido-PEG3-S-PEG4-propargyl
|
Others | Others |
Azido-PEG3-S-PEG4-propargyl is a polyethylene glycol (PEG)-based linker that contains the azide group and propargyl functionality. This linker is designed specifically for the synthesis of proteolysis targeting chimeras (PROTACs)[1]. | |||
T30274 |
Azido-PEG4-Ala-Ala-Asn(Trt)-PAB
|
||
Azido-PEG4-Ala-Ala-Asn(Trt)-PAB is a PEG derivative conjugated with a peptide via an amide bond. The azide group on the PEG end enables Click Chemistry. The hydrophilic PEG spacer increases solubility in aqueous media. | |||
T14448 |
Azido-PEG4-CH2-Boc
|
Others | Others |
Azido-PEG4-CH2-Boc is a four-unit cleavable polyethylene glycol (PEG) linker compound employed in the synthesis of antibody-drug conjugates (ADCs)[1] and PROTACs[2]. This linker is characterized by its azide functional group and PEG backbone, facilitating the conjugation of drugs to antibodies in ADC development and enabling the synthesis of PROTACs utilizing PEG and alkyl/ether moieties. |